Is Marinomed Biotech AG halal to invest in?

As of July 2026, Marinomed Biotech AG 93Z.BE is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Marinomed Biotech AG a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Marinomed Biotech AG using these criteria to determine its compliance status.

Can Muslims buy shares of Marinomed Biotech AG?

Muslim investors may consider investing in Marinomed Biotech AG if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Marinomed Biotech AG classified as NOT HALAL?

Musaffa determines the Shariah status of Marinomed Biotech AG by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Marinomed Biotech AG updated?

The Shariah compliance status of Marinomed Biotech AG may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Marinomed Biotech AG become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Marinomed Biotech AG?

You can check the latest Shariah compliance status of Marinomed Biotech AG on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Marinomed Biotech AG 93Z.BE

Last Updated: Dec 18, 12:00 AM·BE

93Z.BE Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Marinomed Biotech AG is classified as not halal.

NOT HALAL

Report Source: 2024 1st Quarter Report

Marinomed Biotech AG. Stock Analysis 93Z.BE

Germany Health Care Nano Cap Report: Q1, 2024

Marinomed Biotech AG is a biopharmaceutical company, which engages in the development of therapies based on patent protected technology platforms. The company is headquartered in Korneuburg, Niederoesterreich and currently employs 42 full-time employees. The company went IPO on 2019-02-01. The firm operates in two segments such as Virology and Immunology. The company develops antiviral and immunological therapies such as nasal sprays using the respiratory disease antiviral technology platform, Marinosolv and the Carragelose, platform. With the Marinosolv technology platform, it is possible to improve the effectiveness of poorly soluble active ingredients, this technology has the potential to change some therapies in the field of allergy and autoimmune diseases. The Carragelose platform is already used in six different products against viral infections of the respiratory tract. The firm also offers products for the treatment of influenza, combination products for asthmatics, and others. The firm also develops treatments for type I allergies and autoimmune diseases.

Key Statistics of Marinomed Biotech AG (93Z.BE)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€18.30€19.10

Today's Open

€19.10

Volume

10.00

P/E Ratio (TTM)

Financial Metrics & Statements of Marinomed Biotech AG (93Z.BE)

Super Investors Invested in Marinomed Biotech AG (93Z.BE)

FAQ's for Marinomed Biotech AG (93Z.BE)

As of July 2026, Marinomed Biotech AG 93Z.BE is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Marinomed Biotech AG using these criteria to determine its compliance status.
Muslim investors may consider investing in Marinomed Biotech AG if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Marinomed Biotech AG by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Marinomed Biotech AG may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Marinomed Biotech AG on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.